Pulmonary arterial systolic pressure and susceptibility to high altitude pulmonary edema

Respiratory Physiology and Neurobiology

Volumn 179, Issue 2-3, 2011, Pages 294-299

  Mounier, Rémi ^a,b   Amonchot, Aimé ^c   Caillot, Nicolas ^b,d   Gladine, Cécile ^e   Citron, Bernard ^c   Bedu, Mario ^b   Chirico, Erica ^f   Coudert, Jean ^b   Pialoux, Vincent ^b,f  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

^d Société NRC Médical   (France)

^e UMR1213 HERBIVORES   (France)

^f UNIVERSITÉ LYON 1   (France)

Author keywords

Altitude pulmonary disease; Echocardiography; Exercise; Hypoxia

Indexed keywords

MALONALDEHYDE; NITRIC OXIDE; VASCULOTROPIN;

ADULT; ALTITUDE DISEASE; ARTERIAL OXYGEN SATURATION; ARTICLE; DISEASE PREDISPOSITION; DOPPLER ECHOCARDIOGRAPHY; DOPPLER FLOWMETRY; EXERCISE; FEMALE; HEART RATE; HIGH ALTITUDE PULMONARY EDEMA; HUMAN; HUMAN EXPERIMENT; HYPOXIA; LUNG ARTERY PRESSURE; LUNG EDEMA; LUNG GAS EXCHANGE; MALE; MOUNTAINEERING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY ARTERY SYSTOLIC PRESSURE;

ADULT; ALTITUDE SICKNESS; ANOXIA; BLOOD PRESSURE; DISEASE SUSCEPTIBILITY; ECHOCARDIOGRAPHY, DOPPLER; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRATES; NITRITES; PULMONARY ARTERY; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 81155153947     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2011.09.011     Document Type: Article

References (32)

1. Allemann Y., Sartori C., Lepori M., Pierre S., Melot C., Naeije R., Scherrer U., Maggiorini M. Echocardiographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H2013-H2016.
2. Astrand P.O., Ryhming I. A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during sub-maximal work. J. Appl. Physiol. 1954, 7:218-221.
3. Bartsch P., Maggiorini M., Ritter M., Noti C., Vock P., Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N. Engl. J. Med. 1991, 325:1284-1289.
4. Brugniaux J.V., Schmitt L., Robach P., Jeanvoine H., Zimmermann H., Nicolet G., Duvallet A., Fouillot J.P., Richalet J.P. Living high-training low: tolerance and acclimatization in elite endurance athletes. Eur. J. Appl. Physiol. 2006, 96:66-77.
5. Crosswhite P., Sun Z. Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension. J. Hypertens. 2010, 28:201-212.
6. Dehnert C., Grunig E., Mereles D., von Lennep N., Bartsch P. Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude. Eur. Respir. J. 2005, 25:545-551.
7. Grunig E., Mereles D., Hildebrandt W., Swenson E.R., Kubler W., Kuecherer H., Bartsch P. Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. J. Am. Coll. Cardiol. 2000, 35:980-987.
8. Hackett P.H., Rennie D., Levine H.D. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 1976, 2:1149-1155.
9. Hackett P.H., Roach R.C., Hartig G.S., Greene E.R., Levine B.D. The effect of vasodilators on pulmonary hemodynamics in high altitude pulmonary edema: a comparison. Int. J. Sports Med. 1992, 13(Suppl. 1):S68-S71.
10. Hohenhaus E., Paul A., McCullough R.E., Kucherer H., Bartsch P. Ventilatory and pulmonary vascular response to hypoxia and susceptibility to high altitude pulmonary oedema. Eur. Respir. J. 1995, 8:1825-1833.
11. Houston C. Acute pulmonary edema of high altitude. N. Engl. J. Med. 1960, 263.
12. Hultgren H.N., Grover R.F., Hartley L.H. Abnormal circulatory responses to high altitude in subjects with a previous history of high-altitude pulmonary edema. Circulation 1971, 44:759-770.
13. Kehrer J.P., Lund L.G. Cellular reducing equivalents and oxidative stress. Free Radic. Biol. Med. 1994, 17:65-75.
14. Kleinbongard P., Dejam A., Lauer T., Jax T., Kerber S., Gharini P., Balzer J., Zotz R.B., Scharf R.E., Willers R., Schechter A.N., Feelisch M., Kelm M. Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radic. Biol. Med. 2006, 40:295-302.
15. Mortimer H., Patel S., Peacock A.J. The genetic basis of high-altitude pulmonary oedema. Pharmacol. Ther. 2004, 101:183-192.
16. Mounier R., Pialoux V., Robach P., Schmitt L., Richalet J.P., Coudert J., Fellmann N., Clottes E. Effects of acute hypoxia tests on blood markers in high level endurance athletes. Eur. J. Appl. Physiol. 2009, 106:713-720.
17. Mounier R., Pialoux V., Cayre A., Schmitt L., Richalet J.P., Robach P., Lasne F., Roels B., Millet G., Coudert J., Clottes E., Fellmann N. Leukocyte's Hif-1 expression and training-induced erythropoietic response in swimmers. Med. Sci. Sports Exerc. 2006, 38:1410-1417.
18. Mounier R., Pialoux V., Roels B., Thomas C., Millet G., Mercier J., Coudert J., Fellmann N., Clottes E. Effect of intermittent hypoxic training on HIF gene expression in human skeletal muscle and leukocytes. Eur. J. Appl. Physiol. 2009, 105:515-524.
19. Pavlicek V., Marti H.H., Grad S., Gibbs J.S., Kol C., Wenger R.H., Gassmann M., Kohl J., Maly F.E., Oelz O., Koller E.A., Schirlo C. Effects of hypobaric hypoxia on vascular endothelial growth factor and the acute phase response in subjects who are susceptible to high-altitude pulmonary oedema. Eur. J. Appl. Physiol. 2000, 81:497-503.
20. Pialoux V., Mounier R., Ponsot E., Rock E., Mazur A., Dufour S., Richard R., Richalet J.P., Coudert J., Fellmann N. Effects of exercise and training in hypoxia on antioxidant/pro-oxidant balance. Eur. J. Clin. Nutr. 2006, 60:1345-1354.
21. Rathat C., Richalet J.P., Herry J.P., Larmignat P. Detection of high-risk subjects for high altitude diseases. Int. J. Sports Med. 1992, 13(Suppl. 1):S76-S78.
22. Richalet J.P., Kéromés A., Dersch B., Corizzi F., Mehdioui H., Pophillat B., Chardonnet H., Tassery F., Herry J.P., Rathat C., Chaduteau C., Darnaud B. Caractéristiques physiologiques des alpinistes de haute altitude. Sci. Sports 1988, 3:89-108.
23. Rock E., Astier C., Lab C., Malpuech C., Nowacki W., Gueux E., Mazur A., Rayssiguier Y. Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magnes. Res. 1995, 8:237-242.
24. Sartori C., Allemann Y., Trueb L., Delabays A., Nicod P., Scherrer U. Augmented vasoreactivity in adult life associated with perinatal vascular insult. Lancet 1999, 353:2205-2207.
25. Sartori C., Allemann Y., Trueb L., Lepori M., Maggiorini M., Nicod P., Scherrer U. Exaggerated pulmonary hypertension is not sufficient to trigger high-altitude pulmonary oedema in humans. Schweiz. Med. Wochenschr. 2000, 130:385-389.
26. Scherrer U., Vollenweider L., Delabays A., Savcic M., Eichenberger U., Kleger G.R., Fikrle A., Ballmer P.E., Nicod P., Bartsch P. Inhaled nitric oxide for high-altitude pulmonary edema. N. Engl. J. Med. 1996, 334:624-629.
27. Swenson E.R., Maggiorini M., Mongovin S., Gibbs J.S., Greve I., Mairbaurl H., Bartsch P. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA 2002, 287:2228-2235.
28. Thomas S.R., Witting P.K., Drummond G.R. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid. Redox Signal 2008, 10:1713-1765.
29. Vachiery J.L., McDonagh T., Moraine J.J., Berre J., Naeije R., Dargie H., Peacock A.J. Doppler assessment of hypoxic pulmonary vasoconstriction and susceptibility to high altitude pulmonary oedema. Thorax 1995, 50:22-27.
30. Vogel J.A., Harris C.W. Cardiopulmonary responses of resting man during early exposure to high altitude. J. Appl. Physiol. 1967, 22:1124-1128.
31. Walter R., Maggiorini M., Scherrer U., Contesse J., Reinhart W.H. Effects of high-altitude exposure on vascular endothelial growth factor levels in man. Eur. J. Appl. Physiol. 2001, 85:113-117.
32. Yock P.G., Popp R.L. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984, 70:657-662.